News
Due to the COVID-19 pandemic, the AAN urges feds to further expand telehealth benefits
According to the AAN, the easing of restrictions on telehealth should be extended beyond Medicare fee-for-service to both Medicare Advantage and...
News
COVID-19 prompts ‘lifesaving’ policy change for opioid addiction
Patients in some opioid treatment programs will be allowed to take home their medication.
News
Loneliness, social isolation in seniors need urgent attention
Clinicians might be able to prevent or reduce social isolation and loneliness by directly addressing underlying health-related causes, new report...
News
FDA OKs first orally disintegrating agent for rapid migraine relief
This is the first CGRP receptor antagonist available in a fast-acting orally disintegrating tablet for the acute treatment of migraine in adults...
News
Dulaglutide OK for primary, secondary CV risk reduction in U.S.
This marks the first time a GLP-1 receptor agonist for type 2 diabetes has been approved for primary prevention of CV events.
News
FDA okays first generic of ProAir HFA
Generic albuterol sulfate inhalation is indicated for the treatment or prevention of bronchospasm in people aged 4 years or older who have...
News
Severe infection tied to substance-induced psychosis, conversion to schizophrenia
Hepatitis was the infection most strongly linked to psychosis, the research shows.
News
FDA approves weekly contraceptive patch Twirla
The levonorgestrel and ethinyl estradiol contraceptive is contraindicated in obese women.
News
Brain imaging offers new insight into persistent antisocial behavior
"These findings underscore prior research that really highlights that there are different types of young offenders," said coauthor Dr. Essi Viding...
News
FDA approves novel pandemic influenza vaccine
This is the first and only adjuvanted, cell-based pandemic vaccine to provide active immunization against influenza A virus H5N1 strain.
News
Large percentage of psychiatrists sued for malpractice at least once
Among psychiatrists named in a lawsuit, 44% said they were very surprised to be the subject of litigation.
News
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.
News
FDA expands use of Toujeo to childhood type 1 diabetes
Numerically fewer patients taking Toujeo experienced severe hypoglycemia or experienced one or more episodes of...